Social network
Investors - Ensuring sustainable growth
Investors - Ensuring sustainable growth


Ensuring sustainable growth

Tools content (print, share, increase/decrease text size):


Individual shareholders

Dear individual shareholder,
Welcome to this section especially dedicated to you. Throughout these pages we provide our individual shareholders and all those who are interested in our shares with information on the Company’s commitment towards its shareholders.
If you want to learn more about Sanofi, contact the Sanofi Individual Shareholder Relations team in:
France at +33 800 075 876 or
the United States at +1 888 516 3002.



On March 15, 2017, Sanofi participated in a shareholder meeting in Lille.


Q4 and Full Year 2016 Results

Fourth Quarter and Full Year 2016 Results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.


Letter to shareholders - December 2016

Download the Letter to Shareholders - March 2013

This new issue focuses on third-quarter 2016 results, Dupixent®, our investigational treatment for atopic dermatitis, Sanofi Genzyme, the fast-growing Speciality Care business unit and the Salon Actionaria 2016.


2016 Awards - Le Revenu

José Barella

Sanofi wins the Trophée d’Argent (Silver Award) for the Best Shareholders Services for CAC40 companies.



Sanofi makes available to shareholders the estimates of the Analysts Consensus published by Vara Research GmbH.


Right area:

Stock Market

IR mobile application

SANOFI IR - The Investor Relations Mobile Application

SANOFI IR is available on iPhone, iPad, Apple Watch and Android!
NEW - Section dedicated to Individual Shareholders


Annual General Meeting 2017

The Sanofi General Meeting will be held on May 10, 2017 at the Palais de Congrès in Paris, France.


Shareholder Handbook

Sanofi at a glance


© Sanofi 2004-2017 - All rights reserved - Update: March 16, 2017

  • Site complies with W3C WCAG 2.0 (new window, in english)